Vor Biopharma has done well to continue to advance its very own global phase 3 study using its dual BAFF/APRIL inhibitor ...
Canadian equities have recently reached new record highs, buoyed by supportive signals from the Bank of Canada and the Federal Reserve. In this context, penny stocks—though a somewhat outdated ...
A second GIMP 3.2 release candidate (RC) is now available for testing, should you fancy sampling the various changes on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback